Category: Zacks Small Cap Research

12347620 / 755 POSTS
By M. MarinOTC:VQSLF READ THE FULL VQSLF RESEARCH REPORT VIQ Solutions (OTC:VQSLF) operates a technology platform that offers artificial intelligence (AI) enabled with voice-to-text capabilities. The company continues to transition to recurring month ...
NASDAQ:SNES SenesTech, Inc. (NASDAQ:SNES) announced annual financial results for 2019 and provided operational update (Source: Shutterstock) The company reported approximately $140k in revenues, significantly lower than close to $300k the prior yea ...
By Ian Gilson, PhD, CFANASDAQ:MBII READ THE FULL MBII RESEARCH REPORT Marrone Bio Innovations' (NASDAQ:MBII) product, Jet-Oxide 15% Sanitizer, is now allowed by the U.S. EPA for use against the human coronaviruses on hard surfaces in the food industr ...
By David Bautz, PhDNASDAQ:CFRX READ THE FULL CFRX RESEARCH REPORT Business Update Update on Phase 3 DISRUPT Trial In January, 2020, ContraFect Corp. (NASDAQ:CFRX) announced the first patient had been dosed in the Phase 3 DISRUPT (Direct Lysis of St ...
By David Bautz, PhDNASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Positive Topline Results for SGX301 Phase 3 Trial in CTCL On March 19, 2020, Soligenix, Inc. (NASDAQ:SNGX) announced positive topline results for the Phase 3 clinical t ...
By Ian Gilson, PhD, CFANASDAQ:SNES READ THE FULL SNES RESEARCH REPORT The SenesTech (NASDAQ:SNES) consumer website is now active with instructions on how to order and deploy the ContraPest bait stations, as well as a hotline (1-866-886-7287) for reta ...
By David Bautz, PhDNASDAQ:CERC READ THE FULL CERC RESEARCH REPORT Financial Update On March 11, 2020, Cerecor, Inc. (NASDAQ:CERC) announced financial results for the fourth quarter and full year 2019. The company reported net product revenue of $6.7 ...
By David Bautz, PhDNASDAQ:BTAI READ THE FULL BTAI RESEARCH REPORT BioXcel Therapeutics, Inc. (NASDAQ:BTAI) currently has two lead development programs: BXCL501 – a sublingual formulation of the α2a adrenergic receptor agonist dexmedetomidine (Dex) fo ...
By Brian Marckx, CFANASDAQ:MTBC READ THE FULL MTBC RESEARCH REPORT Q4 2019 Results, Operational Update… MTBC Inc (NASDAQ:MTBC) reported financial results for their fourth quarter 2019 and provided a business update. Importantly, management reiterated ...
By David Bautz, PhDTSX:APLI.V READ THE FULL APLI.V RESEARCH REPORT Business Update Appili Therapeutics Inc. (TSX:APLI.V) is a biopharmaceutical company devoted to acquiring and developing novel treatments for infectious diseases. The company was foun ...
12347620 / 755 POSTS